Clinical and Molecular Allergy

Top Research Topics at Clinical and Molecular Allergy?

The journal mostly deals with topics like Allergy, Immunology, Asthma, Immunoglobulin E and Internal medicine. While work presented in it provided substantial information on Allergy, it also covered topics in Dermatology, Disease and Sensitization. Most of the Sensitization studies addressed also intersect with Food allergy.

Clinical and Molecular Allergy aims to investigate interdisciplinary topics such as Immunology and Molecular medicine. The journal explores topics in Asthma which can be helpful for research in disciplines like Atopic dermatitis, Allergen immunotherapy, Pediatrics and Intensive care medicine. In addition to Pediatrics research, the journal aims to explore topics under Alternative medicine and Family medicine.

Basophil activation is a focus of the presented Immunoglobulin E works and it dives deep in Basophil activation. Internal medicine research presented is mostly focused on the subject of Biomarker (medicine).

• Allergy (67.43%)
• Immunology (57.47%)
• Asthma (24.90%)

What are the most cited papers published in the journal?

• Intestinal strongyloidiasis and hyperinfection syndrome (195 citations)
• Immunosenescence in aging: between immune cells depletion and cytokines up-regulation (145 citations)
• House dust mite major allergens Der p 1 and Der p 5 activate human airway-derived epithelial cells by protease-dependent and protease-independent mechanisms (140 citations)

Research areas of the most cited articles at Clinical and Molecular Allergy:

The published papers primarily tackle Immunology, Allergy, Immunoglobulin E, Asthma and Immune system. While Immunology is the focus of the journal papers, it also provides insights into the studies of Inhalation and Disease. The most cited papers tackle research work in Allergy as well as Molecular medicine.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Immune system

The previous edition focused in particular on these issues:

The journal facilitates discussions on Allergy, Internal medicine, Immunoglobulin E, Immunology and Asthma. The concepts on Allergy presented in it can also apply to other research fields, including Dermatology, Occupational safety and health and Disease. While the journal focused on Disease, it was also able to explore topics like Proinflammatory cytokine, Mediator and Pathogenesis.

The studies on Immunoglobulin E discussed can also contribute to research in the domains of Immunoassay, Allergen and Clinical significance. The work on Immunology tackled in the journal brings together disciplines like Antagonist and Histamine. Some problems in Asthma that were presented in it overlapped with concepts under Intensive care medicine, Airway and Chronic condition.

The most cited articles from the last journal are:

• Tropomyosin in mugwort cross-reacts to house dust mite, eliciting non-Th2 response in allergic rhinitis patients sensitized to house dust mite. (2 citations)
• Small airway dysfunction and poor asthma control: a dangerous liaison (1 citations)
• Prescription rate and treatment patterns for allergic rhinitis from 2010 to 2018 in South Korea: a retrospective study. (0 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Clinical and Molecular Allergy (based on the number of publications) are:

• Giorgio Walter Canonica (22 papers) published 2 papers at the last edition the same number as at the previous edition,
• Cristoforo Incorvaia (22 papers) published 1 paper at the last edition, 3 less than at the previous edition,
• Sebastiano Gangemi (22 papers) published 5 papers at the last edition, 1 more than at the previous edition,
• Guha Krishnaswamy (17 papers) absent at the last edition,
• Erminia Ridolo (14 papers) published 1 paper at the last edition the same number as at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical and Molecular Allergy (based on the number of publications) are:

• University of Genoa (26 papers) published 3 papers at the last edition the same number as at the previous edition,
• University of Messina (21 papers) published 4 papers at the last edition the same number as at the previous edition,
• University of Bari (18 papers) published 1 paper at the last edition, 2 less than at the previous edition,
• University of Parma (14 papers) published 1 paper at the last edition the same number as at the previous edition,
• University of Florence (14 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 5.26% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 55.56% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.11% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.11% of all publications and 22.22% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.